Vaccines against seasonal and pandemic influenza and the implications of changes in substrates for virus production.
about
A replicating modified vaccinia tiantan strain expressing an avian-derived influenza H5N1 hemagglutinin induce broadly neutralizing antibodies and cross-clade protective immunity in miceMutations associated with severity of the pandemic influenza A(H1N1)pdm09 in humans: a systematic review and meta-analysis of epidemiological evidence.Host Adaptation and the Alteration of Viral Properties of the First Influenza A/H1N1pdm09 Virus Isolated in JapanDevelopment of high-yield influenza A virus vaccine virusesNew strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.An MDCK cell culture-derived formalin-inactivated influenza virus whole-virion vaccine from an influenza virus library confers cross-protective immunity by intranasal administration in mice.Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells.Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants.Clinical applications of DNA vaccines: current progress.The DBA.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B viruses.Protease activation mutants elicit protective immunity against highly pathogenic avian influenza viruses of subtype H7 in chickens and mice.Trivalent inactivated influenza vaccines induce broad immunological reactivity to both internal virion components and influenza surface proteins.Antigenic characterization of influenza viruses produced using synthetic DNA and novel backbones.The future of cell culture-based influenza vaccine production.The influenza vaccine innovation system and lessons for PDPs.Considerations for setting the specifications of vaccines.Principles underlying rational design of live attenuated influenza vaccines.Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing.
P2860
Q30357094-F63E376E-6738-4E21-9FC2-9AD00D8363B9Q30365296-03F33D25-8E01-426D-B3B7-E09842BA2091Q30375713-E35E986A-0708-4293-BF2D-A363C34963EEQ30378710-AA956C7D-5A15-4DE4-A00E-5949708E894EQ30407424-453774D2-06C6-4BA3-97C4-624F62DCE173Q30430005-7F2A3404-F9DB-4BED-B64F-5951BEE9BE1FQ34055396-EB3ED537-6BFA-4932-BD6B-0AAE1EB6E121Q34279996-B49C26C4-59E6-4B98-AF4C-08B01332CF55Q35452312-5AFF83B9-4FFA-4C7F-8A4A-7CBAC26EE13EQ35531496-7169960F-78CF-4E88-8F49-C17FE71B1963Q36778856-D8792C21-7E1F-4D37-9FDB-0378FBAECAF3Q36950550-FA1EEC11-B24F-448C-B94A-287DC29F599DQ37083396-D31D94F0-2AC5-4139-B70C-11AA4D2270CEQ37919896-EAEB269B-D0DB-4EFB-AFEA-D2C9AE8E5FE8Q37983417-E01E30E7-90E4-4B96-ADD0-4AE64BCDE674Q38028995-24BA1AC0-BFE6-40B2-BC1D-000F929E76D3Q39770895-BCCB1D2B-AD8F-42A5-9D0C-C655078A7A49Q42209364-432EF8EB-4F35-4C61-BE1D-07928A7A15BD
P2860
Vaccines against seasonal and pandemic influenza and the implications of changes in substrates for virus production.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Vaccines against seasonal and ...... bstrates for virus production.
@ast
Vaccines against seasonal and ...... bstrates for virus production.
@en
type
label
Vaccines against seasonal and ...... bstrates for virus production.
@ast
Vaccines against seasonal and ...... bstrates for virus production.
@en
prefLabel
Vaccines against seasonal and ...... bstrates for virus production.
@ast
Vaccines against seasonal and ...... bstrates for virus production.
@en
P356
P1476
Vaccines against seasonal and ...... bstrates for virus production.
@en
P2093
Philip D Minor
P304
P356
10.1086/650171
P407
P577
2010-02-01T00:00:00Z